Malaria is one of the world’s leading killers, claiming the lives of over 250,000 children in Africa every year. Researchers have been trying for decades to come up with a viable solution to this global health problem, but haven’t made much progress. That is, until recently. This week, the world’s first malaria vaccine has begun a wide rollout, commencing in Malawi before being introduced into Ghana and Kenya over the following weeks. The RTS/S vaccine, currently the most advanced malaria vaccine in development, works by training the immune system to attack the malaria parasite, which is spread by mosquitos. The vaccine has been shown to prevent nearly 40 percent of malaria cases. While this isn’t an extraordinarily efficacious rate for a vaccine, it could still save thousands of lives in affected African areas. This initial pilot program is estimated to run until 2024, after which the results will be evaluated and broader implementation in other countries will be considered.
Pioneering malaria vaccine to roll out in Malawi
More of Today's Solutions
From molten salt to liquid air: clean energy’s weird storage revolution
BY THE OPTIMIST DAILY EDITORIAL TEAM There’s something strange about where the clean energy transition has gotten stuck. Generating power from the sun and ...
Read MoreSoft decluttering: the low-pressure method for a tidier home
BY THE OPTIMIST DAILY EDITORIAL TEAM You know the feeling: you walk toward the hall closet with good intentions, reach for the handle, and ...
Read More5 expert-recommended ways to cope with holiday stress
Financial strain, social pressure, and countless to-dos make the period between Thanksgiving and New Year's the most stressful time of year, according to numerous ...
Read MoreOslo’s quiet revolution: how electric construction sites are changing the game
BY THE OPTIMIST DAILY EDITORIAL TEAM Imagine walking past a bustling construction site and hearing… almost nothing. In Oslo, that’s becoming the new normal. ...
Read More
